Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical features of MDS.

T Hamblin1

  • 1Royal Victoria Hospital, Bournemouth, U.K.

Leukemia Research
|January 1, 1992
PubMed
Summary

Myelodysplastic syndromes (MDS) primarily affect the elderly, presenting with anemia, neutropenia, and thrombocytopenia. Dysfunctional hematopoietic tissue can lead to severe infections and bleeding, even with normal counts.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autumn Books: The paranormal defended.

British medical journal (Clinical research ed.)·2010
Same author

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.

Lancet (London, England)·2007
Same author

Disturbances in peripheral blood B cell subpopulations in autoimmune patients.

Lupus·2003
Same author

Chronic lymphocytic leukaemia: one disease or two?

Annals of hematology·2002
Same author

Historical aspects of chronic lymphocytic leukaemia.

British journal of haematology·2001
Same author

Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000

Area of Science:

  • Hematology
  • Oncology

Background:

  • Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell diseases.
  • Primarily affecting the elderly, MDS can also occur in younger individuals with exposure to specific environmental factors.

Purpose of the Study:

  • To summarize the key clinical features and pathological effects of Myelodysplastic Syndromes (MDS).
  • To highlight the complications and management considerations in MDS patients.

Main Methods:

  • Review of clinical presentations and laboratory findings in MDS patients.
  • Analysis of pathological consequences arising from hematopoietic tissue dysfunction.

Main Results:

  • Common clinical features include anemia, neutropenia, and thrombocytopenia.
  • Hematopoietic dysfunction can lead to severe infections and bleeding, sometimes with normal neutrophil or platelet counts.
  • Specific to chronic myelomonocytic leukemia (CMML), a subtype of MDS, are monocyte proliferation, organomegaly, and immune complex-related lesions.

Conclusions:

  • MDS presents with significant hematological abnormalities and potential for severe complications.
  • Management requires attention to transfusion support and prevention of iron overload.
  • While cancer is not more common, coincident lymphoid tumors can occur.

Related Experiment Videos